Subscribe To Our Free Newsletter |
Glenmark Pharma net loss widens to Rs 1,239 cr in Q4 FY24
Glenmark Pharmaceuticals reported net loss of Rs 1,238.64 crore in Q4 FY24 as compared with net loss of Rs 549.49 crore in Q4 FY23.